Editors' ChoiceCancer

Less is more for anticancer therapy combinations

See allHide authors and affiliations

Science Translational Medicine  11 Oct 2017:
Vol. 9, Issue 411, eaap8166
DOI: 10.1126/scitranslmed.aap8166

You are currently viewing the abstract.

View Full Text

Abstract

Withdrawal of MAPK inhibition sensitizes cancer cells to DNA repair–targeting drugs.

View Full Text